±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 430  |  »Ø¸´: 2
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

lx_cpu

гæ (³õÈëÎÄ̳)

[½»Á÷] Ê׽조¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌֻᡱµÄ֪ͨ£¨µÚ¶þÂÖ£©

¹ØÓÚ¾Ù°ìÊ׽조¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌֻᡱµÄ֪ͨ
£¨µÚ¶þÂÖ£©

¸÷Óйص¥Î»£º
ΪʹÎÒ¹úÒ½Ò©¹¤×÷Õß¼°Ê±°ÑÎÕ¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§·¢Õ¹¶¯Ì¬£¬¼Ó¿ì´´ÐÂÒ©ÎïÑо¿Ó뿪·¢£¬Íƶ¯ÎÒ¹ú¹¤ÒµÒ©Ñ§¡¢ÁÙ´²Ò©Ñ§ºÍÖÎÁÆÑ§¿ÆµÄ¿ìËÙ·¢Õ¹£¬ÖÐɽ´óѧ¡¢¹ã¶«Ê¡Ò©Ñ§»á¡¢»ªÄÏÐÂÒ©´´ÖÆÖÐÐÄÓë¼ÓÄôóÂó»ù¶û´óѧ¶¨ÓÚ2009Äê10ÔÂ9ÈÕÖÁ11ÈÕÔڹ㶫ʡ¹ãÖÝÊоÙÐС°¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌֻᡱ¡£
±¾»áÒ齫¹¹½¨Ò»¸ö¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§½»Á÷µÄƽ̨£¬ÃÜÇÐѧÊõ½ç¡¢ÆóÒµ½ç¡¢Õþ¸®µÄÁªÏµ£¬´Ù½øÏà¹Ø²úÒµµÄ·¢Õ¹£¬¼ÓÇ¿¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÁìÓòµÄ¹ú¼ÊºÏ×÷£¬Íƶ¯ÎÒ¹úÖÆÒ©²úҵʵÏÖÓÉ·ÂÖÆÏò×ÔÖ÷´´ÐÂÑÐÖÆµÄÀúÊ·ÐÔת±ä¡£
×éί»áÒÑÑûÇë¹úÄÚÍâ´Óʹ¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÁìÓòµÄר¼Ò½øÐÐѧÊõÑÐÌÖ£¬»¶Ó­¸÷Óйص¥Î»Óë»á½»Á÷¡£
ÓйØÊÂÏî֪ͨÏê¼û¸½¼þ¡£


¹ú¼Ê¹¤ÒµÒ©Ñ§ºÍÁÙ´²Ò©Ñ§ÑÐÌÖ»á×éί»á£¨´úÕ£©
           2009Äê9ÔÂ16ÈÕ

¸½¼þ

Ò»¡¢»áÒé×éÖ¯
Ö÷°ìµ¥Î»£ºÖÐɽ´óѧ
¹ã¶«Ê¡Ò©Ñ§»á
»ªÄÏÐÂÒ©´´ÖÆÖÐÐÄ
¼ÓÄôóÂó»ù¶û´óѧ
³Ð°ìµ¥Î»£ºÖÐɽ´óѧҩѧԺ
          ¹ã¶«Ê¡Ò©Ñ§»áÖÆ¼ÁרҵίԱ»á
          ¹ã¶«Ê¡¸ßУ´´ÐÂÒ©ÎïÖÆ¼Á¹¤³Ì¼¼ÊõÑо¿ÖÐÐÄ
          ¼ÓÄôóÂó»ù¶û´óѧҽÁÆÖÐÐÄ

´ó»áÖ÷ϯ£º³ÂÐÂ×ÌԺʿ£¬James W. McGinity
´ó»áѧÊõίԱ»á
Ö÷ÈÎίԱ£ºÖܺêå°ÔºÊ¿£¬Áõ²ýТԺʿ
¸±Ö÷ÈÎίԱ£º¶Å¹Ú»ª¡¢ÍõÄþÉú¡¢ÑÕ¹âÃÀ¡¢»Æ  Ãñ¡¢Guru Betageri
ίԱ£º³Â  Ð¢¡¢¹ùÏþµÏ¡¢½ð  ·½¡¢Áõ  »¢¡¢ÁõÅàÇì¡¢ÁõÏþÓ¬  ì¿¡¢Ã·Ð˹ú¡¢ÅËÎÀÈýƽÆäÄÜ¡¢É꾩½¨¡¢Ëï  º×¡¢Ëï  Ñ·¡¢Î⠠ΰ¡¢Ó¡´º»ª¡¢ÔÀ  ½ø¡¢ÖÓÃ÷¿µ¡¢Öܽ¨Æ½
      Hak-Kim Chan, Joel Moss, Michael A. Repka, Rongtuan Lin, Albert Wai-Kit Chan, Richard Y. Ho, Scott M Wheelwright, Mingyao Liu, Ningling Wang, Grace Wong,
Ilho Kim, Seiji Shibasaki, Tianru Jin, Takashi Yamaki

¶þ¡¢²¿·Ö´ó»á±¨¸æ        
³ÂÐÂ×ÌԺʿ£¬ÖÐɽ´óѧҩѧԺ  ÃûÓþÔº³¤
Ö»¶Ó­´Ç
Áõ²ýТԺʿ£¬Ìì½òÖÐÒ½Ò©´óѧ  ÖÐҩѧԺԺ³¤
ÌâÄ¿£ºÌâÄ¿´ý¶¨
Öܺêå°ÔºÊ¿£¬ÖÐÄÏ´óѧÁÙ´²Ò©ÀíÑо¿ËùËù³¤
ÌâÄ¿£ºÌâÄ¿´ý¶¨

ÒÔϰ´ÐÕÊÏ×Öĸ˳ÐòÅÅÁÐ

Betageri, Guru    Professor and Chair of Pharmaceutical Sciences,
Western University of Health Science, USA
ÌâÄ¿£ºApplication of Nanoparticles for Cancer Therapy and Diagnostics

Chan, Albert Wai-Kit    Professor of The City University of New York, USA
ÌâÄ¿£ºIntellectual Property Considerations of Industrial Pharmaceutics and Clinical Pharmacology

Chan, Hak-Kim    Professor in Pharmaceutics, University of Sydney, Australia
ÌâÄ¿£ºThe Development of Mannitol for Iinhalation as a Successful Commercial Product

Chen, Jiwen    Principal Scientist of Bristol-Myers Squibb
ÌâÄ¿£ºThe Evolving Role of Personalized Medicine in Healthcare

¶Å¹Ú»ª    Öйúҽѧ¿ÆÑ§ÔºÒ©ÎïÑо¿Ëù¸±Ëù³¤£¬Ò©ÎïɸѡÖÐÐÄÖ÷ÈΣ¬½ÌÊÚ
ÌâÄ¿£ºÌâÄ¿´ý¶¨


Ferguson, Alesia    Environmental and Occupational Health College of Public Health,
                  UAMS, USA
ÌâÄ¿£ºLooking at Adherence to the Human Skin for Chemical Uptake: Use of a Computer Controlled Mechanical Chamber.

Ganguly, Sid    Associate Professor of Medicine Division of Hematology/Oncology University of Kansas Medical College Cancer Center, USA
ÌâÄ¿£ºLow-dose Cidofovir in the Treatment of Symptomatic BK Virus Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Ge, Albert    Associate Director Novartis Develop New Product Through Open Innovation
ÌâÄ¿£ºDevelop New Product Through Open Innovation

Guo, Xiaodi    Executive Vice President of Huahai US Inc.
ÌâÄ¿£ºUS Generic Product Development, Registration and Approval


Ho, Richard Y    Director, Mfg. Technologies Bristol-Myers Squibb Co
ÌâÄ¿£ºPharmaceutical Technology & Technical Transfer for New Product Registration and Product Launch

»Æ  Ãñ    ÖÐɽ´óѧҩѧԺԺ³¤£¬½ÌÊÚ
ÌâÄ¿£ºÌâÄ¿´ý¶¨

½ð  ·½    ÉϺ£Ò½Ò©¹¤ÒµÑо¿Ôº½ÌÊÚ£¬Ö÷ÈÎ
ÌâÄ¿£ºÖйúÎüÈëÖÆ¼ÁµÄ·¢Õ¹Ó빤ҵ»¯

Jin, Tianru    Associated professor Faculty of Medicine, University of Toronto
ÌâÄ¿£ºMechanisms Underlying the Expression and Function of the Therapeutic Hormone Glucagons-like Peptide-1

Kim, Ilho    GCOE Researcher, Kyoto University
ÌâÄ¿£ºRemoval of Residual Pharmaceuticals in Wastewater with Physicochemical Wastewater Treatment Processes

Liu, Hu    Professor School of Pharmacy, Memorial University of Newfoundland, Canada
ÌâÄ¿£ºTargeted Delivery of Diagnostic Drugs for Early Detection of Atherosclerosis

Liu, Mingyao    Professor and Director, University of Health Network
ÌâÄ¿£ºSelf-Assembly Peptide Based Nano-drug Delivery

ÁõÏþÓî    Õã½­º£Õý¼¯ÍÅÓÐÏÞ¹«Ë¾¼¼ÊõÖÐÐÄÖ÷ÈÎ
ÌâÄ¿£ºA Noval Perixosome Proliferator-activated Receptor Delta Agonist HS060098, Improving Both Dislipidemia and Obesity

¬  ì¿    ±±¾©´óѧҩѧԺ½ÌÊÚ
ÌâÄ¿£º»·æßËØA/Ëû¿ËĪ˾µÄȺÌåÒ©ÎﶯÁ¦Ñ§Ä£ÐÍÓëÁÙ´²¸öÌ廯¸øÒ©

÷Ð˹ú     ¾üÊÂҽѧ¿ÆÑ§Ôº¶¾ÎïÒ©ÎïÑо¿Ëù£¬Ö÷ÈÎ
ÌâÄ¿£ºÒ½Ò©ÆóÒµÐÂÒ©Ñз¢Ä£Ê½Ñ¡ÔñÓë²ßÂÔ

Miwa, Yoshikazu    Assistant professor Department of Clinical Pharmacology,
Kyushu University, Japan
ÌâÄ¿£ºRole of Aldosterone on the Oxidative Stress Generation in the Vascular Wall.
      Possibility of Aldosterone Receptor Antagonist

Moss, Joel    Vice Chief of Translational Medicine Branch, NHLBI,
             Chair of institutional Review Board of NHLBI/NIH.
ÌâÄ¿£ºClinical Research: How to Prepare for the Next Decade


Onoue, Satomi    School of Pharmaceutical Sciences, University of Shizuoka
ÌâÄ¿£ºNovel Formulation Technologies for Improving Therapeutic Potential of Peptides/Proteins

ÅËÎÀÈý    ÉòÑôÒ©¿Æ´óѧҩѧԺ½ÌÊÚ
ÌâÄ¿£ºÌâÄ¿´ý¶¨

ƽÆäÄÜ    ÖйúÒ©¿Æ´óѧҩѧԺ½ÌÊÚ
ÌâÄ¿£ºBCS2Ò©Îï×Ô΢ÈéµÄ¹ÌÌ廯¼°ÆäÈܳö¶ÈÓëÉúÎïÀûÓöÈÑо¿

Repka, Michael A    Professor of Pharmaceutics, School of Pharmacy,
                  The University of Mississippi
ÌâÄ¿£ºUse of Polymer Blends for Pharmaceutical Applications

Sawaki, Akira    Physician-in-Chief,
Department of Gastroenterology Aichi Cancer Center Hospital
ÌâÄ¿£ºSignificance of Chemoradiation for Locally Advanced Pancreatic Cancer

Shibasaki, Seiji    School of Pharmacy Hyogo University of Health Sciences
ÌâÄ¿£ºMolecular Display S ystem Provides Powerful Tool for the Screening of Therapeutic Proteins

Ëï  º×    Ìì½òÌìÊ¿Á¦¼¯ÍŸ±×ܲÃ
ÌâÄ¿£ºÁÙ´²Ò©Ñ§ÔÚÐÂÒ©Ñз¢Óë¹ÜÀíÖеÄÓ¦Ó᪡ªFDA¾­Ñé̸

Ëï  Ñ·    ËÄ´¨´óѧ»ªÎ÷ҩѧԺ½ÌÊÚ
ÌâÄ¿£ºÑª¹ÜÄÚ×¢ÉäÓø¨ÁϵÄÑо¿

Takashi Azuma    Kyoto University, JAPAN
ÌâÄ¿£º Occurrence of Pharmaceuticals and Personal Care Products in the Water Environment

Wang, Ningling    Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
ÌâÄ¿£ºObtaining Winning Patents for FDA Orange Book

Wei, Bill    ҩѧԺ¿Í×ù½ÌÊÚ£¬ ÃÀ¹úÐÂÔóÎ÷ÖÝRugters´óѧ
ÌâÄ¿£ºÐÂÐÍÒ©ÎïÖÆ¼Á²úÆ·ÔÚ¹ú¼ÊÊг¡µÄ»ú»á

Wheelwright, Scott M    President and CEO,
                      Asia Specialist Strategic Manufacturing Worldwide, Inc
ÌâÄ¿£ºBringing Pharmaceutical Products to Market in the United States

Wong, Grace    Founder, Chief Scientific Officer & President ActoKine Therapeutics
ÌâÄ¿£ºIdentification of AK-1 for Radioprotection and AK-2 for Protection Against A Broad- spectrum Viral Infection


Î⠠ΰ    ¸´µ©´óѧҩѧԺ¸±Ôº³¤£¬½ÌÊÚ
ÌâÄ¿£ºFluid-bed Coating as a New Technique to Prepare Solid Dosage Forms From Liquids

Xia, Mingde    Senior Director, Johnson & Johnson COSAT SAPA President, 2008-2009
ÌâÄ¿£ºJohnson & Johnson's Open Innovation Strategy

Yamaki, Takashi    Department of Plastic and Reconstructive Surgery,
                 Tokyo Women¡¯s Medical University
ÌâÄ¿£ºCombined Use of Pretest Clinical Probability Score and Latex Agglutination D-dimer Testing for Excluding Acute Deep Vein Thrombosis

ÑÕ¹âÃÀ    ÖÐɽ´óѧ¸±Ð£³¤»ªÄÏÐÂÒ©´´ÖÆÖÐÐÄÖ÷ÈÎ
ÌâÄ¿£º»ªÄÏÐÂÒ©´´ÖÆÖÐÐĽ¨Éè¹æ»®

Yang, Xiaowei    Division of Biostatistics, Department of Public Health Sciences,
University of California, USA
ÌâÄ¿£ºAnalysis of Incomplete Longitudinal Data with Binary Outcomes

Yasojima, Makoto    Associate Professor, Graduate School of Engineering, Kyoto University
ÌâÄ¿£ºA New Social Concern, Pharmaceuticals as Water Environmental Pollutant

Ó¡´º»ª    ¸´µ©´óѧÉúÃü¿ÆÑ§Ñ§Ôº½ÌÊÚ.
ÌâÄ¿£ºChitosan-based Nanocarriers for Iimproved Drug Delivery

ÔÀ  ½ø    ʯ¼Ò×¯ÖÆÒ©¼¯ÍÅÖ´ÐÐ×ܲÃ
ÌâÄ¿£ºÐÂÐÎÊÆÏµĹúÄÚÒ½Ò©²úÒµ´´ÐÂ̽Ë÷

Öܽ¨Æ½    ÖйúÒ©¿Æ´óѧҩ¼Áѧ½ÌÑÐÊÒÖ÷ÈÎ
ÌâÄ¿£ºÏÖ´úÒ©¼ÁѧÑо¿½øÕ¹

Zhang,Dong    Staff Scientist ICBB-Pfizer
ÌâÄ¿£ºExploring De-ubiquitination Enzymes (DUB) as Novel Anti-cancer Therapy Targets

Zhou, Charlie    Team Leader, Perrigo Pharmaceutical Company
ÌâÄ¿£ºStrategies and Approaches to Modernization of Chinese Materia Medica

Zhou, Ming-Sheng    University of Miami Miller School of Medicine, USA
ÌâÄ¿£ºMechanism Underlying Statins Mitigation of Cardiovascular and Renal Injury in Salt-sensitive Hypertension.



Èý¡¢´ó»á×éί»á
Ö÷ÈÎίԱ£ºÎâ´«±ó
¸±Ö÷ÈÎίԱ£º³Â  Ð¢¡¢Õſ˼ᡢµË½£ÐÛ¡¢Â½  Ò£
ίԱ£º²ÌÉܻԡ¢³Â½¨º£¡¢³Â³ԭ¡¢³ÂÑàÖÒ¡¢³ÂÕñµÂ¡¢³Ì¹ú»ª¡¢·ë  Ãô¡¢·ëÎÄÖÜ¡¢¸ß³ç¿­¡¢
ºÎÑÞÁá¡¢ºîÁ¬±ø¡¢»Æºì±ø¡¢¼¾°®Ãñ¡¢Àî¹ú³É¡¢ÀèÊïϼ¡¢ÀîÔ˾°¡¢ÁõÊÀÃ÷¡¢ÂíÏþð¿¡¢
ʯ  ÀÚ¡¢Ì·ÊØÓ¡¢Ìƺé÷¡¢Îâ  ÁÕ¡¢ÎâÏþÁá¡¢ÎâÏþËÉ¡¢ÎâÐÂÈÙ¡¢Ð¤º£Åô¡¢Ð¤ÏæÁÖ¡¢
ÐìÔº졢ÑÏÅô¿Æ¡¢Ñî´úºê¡¢Ñî  ·«¡¢Ñî  Ãô¡¢Ò¶Àö¿¨¡¢ÓàÃô±ó¡¢ÕÅÓÀÃ÷¡¢ÕÅÖÒÒå¡¢
Ö£Ö¾»ª¡¢Öì¹â׿¡¢ÖìÉÙè¯

ËÄ¡¢»áÒéʱ¼äµØµã
ʱ¼ä£º2009Äê10ÔÂ9ÈÕ-11ÈÕ£¨9ÈÕÈ«Ì챨µ½£©
µØµã£º¹ãÖݹúµÂ¹ú¼Ê´ó¾Æµê£¨¹ãÖÝÊÐÌìºÓ¶«Â·153ºÅ¹úµÂ´óÏã©
³Ë³µÂ·Ïߣº
1. ´Ó¹ãÖݰ×ÔÆ¹ú¼Ê»ú³¡(лú³¡)»ú³¡¿ìÏßB³Ë³µÇø×ø¿Õ¸Û¿ìÏß2ºÅÏßB(»ú³¡ÖÁԣͨ´ó¾Æµê)ÖÁ»ú³¡¿ìÏß×Üͳ´ó¾Æµê£¬µ½Âí·¶ÔÃæµÄ¸Ú¶¥Õ¾2ת³Ë298·ÖÁÌìºÓ¶«Â·Õ¾¡£Ï³µ×ßÔ¼320Ãס£
2. ´Ó¹ãÖÝ»ð³µÕ¾×ÜÕ¾×ø234·»ò33·µ½¸Ú¶¥Õ¾1£¬Ï³µ×ßÔ¼540Ãס£

Îå¡¢»áÎñ·ÑÓ㺠      
800Ôª/ÈË£¬ÔÚ¶Á²©Ê¿¼°Ë¶Ê¿Ñо¿Éú400Ôª/ÈË£¨Æ¾ÓÐЧѧÉúÖ¤¡¢Éí·ÝÖ¤£©¡£
±¸×¢£º×¡ËÞ»áÎñ×éͳһ°²ÅÅ£¬·ÑÓÃ×ÔÀí¡£

Áù¡¢Ê³ËÞ°²ÅÅ
1. סËÞ°²ÅÅ£¨×ÔԸѡÔñ£©
¹ãÖݹúµÂ¹ú¼Ê´ó¾Æµê£¨ÎåÐǼ¶£©
µØµã£º¹ãÖÝÊÐÌìºÓ¶«Â·153ºÅ¹úµÂ´óÏÃ
ºÀ»ªË«ÈË·¿£º 420ÈËÃñ±Ò/¼ä/Ìì
2. ×éί»á½«ÎªÓë»á´ú±íͳһ°²ÅÅ10ÔÂ9ÈÕÍí²ÍÖÁ11ÈÕÍí²Í£¬Óò͵ľßÌåʱ¼äºÍµØµã½«ÁíÐÐ֪ͨ¡£Óë»á´ú±í½«ÔÚ×¢²áʱÁìÈ¡²Íȯ£¬Æ¾È¯Óòͣ¬Ê£Óà²Íȯ²»Í˿
Æß¡¢ÁªÏµ·½Ê½£º
µØ    Ö·£ºÖйú¹ã¶«Ê¡¹ãÖÝÊдóѧ³ÇÍâ»·¶«Â·132ºÅÖÐɽ´óѧҩѧԺ
ÓÊ    ±à£º510006
µç    »°£º020-39943120
ÊÖ    »ú£º13539753131
´«    Õæ£º020-39943119£¬020-39943120
Áª ϵ ÈË£º°×ѩȺ
µç×ÓÓÊÏ䣺IPCP2009@yahoo.com.cn
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

472514568

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

Сľ³æÒéÕþ´ó³¼¼æÐ­°ì´óѧʿ

¶¥ÆðÀ´Å¶
±£³ÖÐÄÁéµÄ´¿½à
2Â¥2009-10-10 14:21:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

DlL2007

¹Ø×¢ÖÐ...
3Â¥2009-10-10 14:42:23
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lx_cpu µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏר˶ 085600Çóµ÷¼Á +7 BBQ233 2026-03-30 7/350 2026-03-30 17:44 by oooqiao
[¿¼ÑÐ] 297Çóµ÷¼Á +14 ÌïºéÓÐ 2026-03-26 15/750 2026-03-30 17:42 by Çç¿Õ210210
[¿¼ÑÐ] 26¿¼ÑÐ-291·Ö-ÏÃÃÅ´óѧ£¨085601£©-ÈáÐÔµç×ÓѧԺ²ÄÁϹ¤³ÌרҵÇóµ÷¼Á +4 min3 2026-03-24 5/250 2026-03-30 16:41 by Àæ×Ó¡«
[¿¼ÑÐ] 303Çóµ÷¼Á +7 DLkz1314. 2026-03-30 7/350 2026-03-30 16:05 by shuang5186
[¿¼ÑÐ] 070300»¯Ñ§354Çóµ÷¼Á +7 101´ÎÏ£Íû 2026-03-28 7/350 2026-03-30 13:22 by Iveryant
[¿¼ÑÐ] Ò»Ö¾Ô¸ºÓ±±¹¤Òµ´óѧ0817»¯¹¤278·ÖÇóµ÷¼Á +14 jhybd 2026-03-23 19/950 2026-03-30 10:34 by vgtyfty
[¿¼ÑÐ] 275Çóµ÷¼Á +15 Micky11223 2026-03-25 20/1000 2026-03-29 20:44 by ÌÆãå¶ù
[¿¼ÑÐ] µ÷¼Á310 +12 ÎÂÈáµÄÍí°² 2026-03-25 13/650 2026-03-29 20:01 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶£¬×Ü·Ö289·Ö +7 @taotao 2026-03-29 7/350 2026-03-29 12:03 by longlotian
[¿¼ÑÐ] 283Çóµ÷¼Á +3 A child 2026-03-28 3/150 2026-03-28 15:41 by ms629
[¿¼ÑÐ] 394Çóµ÷¼Á +3 ºÃʶàÄ¥¾²ºò¼ÑÒ 2026-03-26 5/250 2026-03-28 14:24 by ÌÆãå¶ù
[¿¼ÑÐ] ÕÅ·¼Ãú-Öйúũҵ´óѧ-»·¾³¹¤³Ìר˶-298 +4 ÊÖ»úÓû§ 2026-03-26 4/200 2026-03-28 07:17 by mmm just
[¿¼ÑÐ] Çóµ÷¼Á +4 Áã°Ë# 2026-03-27 4/200 2026-03-27 18:07 by yu221
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á +4 RipcordÉϰ¶ 2026-03-27 4/200 2026-03-27 17:00 by zhyzzh
[¿¼²©] 26É격 +3 ¼ÓÓͳ尡£¡ 2026-03-26 3/150 2026-03-27 15:38 by cls512
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸ÄÏÅ©083200ʳƷ¿ÆÑ§Ó빤³Ì +5 XQTJZ 2026-03-26 5/250 2026-03-27 14:49 by ¿ñìÅÂóµ±µ±
[¿¼ÑÐ] 322Çóµ÷¼Á +4 ÎÒÕæµÄºÜÏëѧϰ 2026-03-23 4/200 2026-03-27 13:51 by ÑîÑîÑî×Ï
[¿¼ÑÐ] 324Çóµ÷¼Á +5 hanamiko 2026-03-26 5/250 2026-03-27 10:33 by wangjy2002
[¿¼ÑÐ] Çóµ÷¼Á +6 ÁÖ֮Ϧ 2026-03-24 6/300 2026-03-27 08:38 by hypershenger
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯315 Çóµ÷¼Á +3 akrrain 2026-03-24 3/150 2026-03-24 19:35 by ÁËÁËÁËÁË¡£¡£
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û